Keros Therapeutics KROS Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	255.25M	235.14M	226.66M	252.55M	306.78M	384.44M	356.31M	326.25M
Total Current Assets	251.44M	231.22M	222.36M	245.88M	285.77M	362.22M	334.31M	304.44M
Cash and Equivalents	230.04M	228.59M	215.62M	239.43M	279.05M	351.43M	322.03M	287.89M
Total Non-Current Assets	5.15M	3.92M	4.3M	6.68M	23.04M	22.21M	22M	21.81M
Total Liabilities	12.08M	11.65M	15.45M	11.53M	29.36M	29.45M	30.05M	30.41M
Total Current Liabilities	11.85M	11.65M	15.45M	11.53M	16.55M	15.46M	16.1M	16.7M
Total Non-Current Liabilities	231k	0	0	0	12.81M	13.99M	13.95M	13.7M
Common Equity	2k	2k	2k	2k	2k	3k	3k	3k
Retained Earnings	-123.76M	-147.94M	-175.21M	-198.72M	-228.43M	-264.24M	-301.74M	-341.18M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	27.41M	10.96M	269.44M	255.25M	306.78M	370.03M
Total Current Assets	25.53M	8.93M	267.73M	251.44M	285.77M	347.29M
Cash and Equivalents	23.26M	7.02M	265.88M	230.04M	279.05M	331.15M
Total Non-Current Assets	-7.18M	-19.45M	261.72M	243.17M	277.42M	332.21M
Total Liabilities	14.65M	10.46M	7.72M	12.08M	29.36M	37.81M
Total Current Liabilities	11.47M	4.49M	7.18M	11.85M	16.55M	24.37M
Total Non-Current Liabilities	3.19M	5.97M	538k	231k	12.81M	13.44M
Total Equity	-7.18M	-19.45M	261.72M	243.17M	277.42M	332.21M
Common Equity	1,000	1,000	2k	2k	2k	3k
Retained Earnings	-7.31M	-19.65M	-65.01M	-123.76M	-228.43M	-381.43M